Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
PLoS One 8:e54794
Expanding application scope to explore interventions in aging-related diseases (neurodegenerative diseases, cardiovascular diseases, metabolic diseases), providing new strategies for their prevention and treatment
FOXO4-DRI works by disrupting the interaction between the FOXO4 protein and p53, enabling p53 to activate apoptosis in senescent cells
Meaning we have no clinical evidence that it works
Detection windows vary from a few hours to several weeks depending on the peptide
US$ 29.74
US$ 25.85
US$ 28.83
US$ 24.00
US$ 21.51
US$ 26.26
US$ 22.76
US$ 24.28
